Comparison of biological data between the failure and the non-failure groups.
dataset
posted on 2024-01-02, 19:00 authored by Natsuki Ishida, Kenichi Takahashi, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Ken SugimotoComparison of biological data between the failure and the non-failure groups.
History
Usage metrics
Categories
Keywords
xlink "> antiinvestigate serum albumin738 8211tumor necrosis factorifx ), adalimumabclinically active patientsbiological data showedadalimumab pulcerative colitis treatedulcerative colitisbiological dataprognostic factorfour patientsuc treatedweek 2two groupstherapeutic effectsignificantly highersignificant differenceoperating characteristicincluding infliximabgroup analysiscrucial positionconfidence intervaladvanced therapyada ),999 ).- 945
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC